Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00814333 · ClinicalTrials.gov registry record · NA

Trial Comparing Outcomes With Merocel Packing or Thrombin-JMI for Anterior Epistaxis

A NA study, sponsored by University of Kansas Medical Center.

Terminated
Registry status
NA
Development phase
1
Enrollment target

NCT00814333: Clinical Trial NA study, sponsored by University of Kansas Medical Center.

NCT00814333 is a NA study that was terminated before completion, run by University of Kansas Medical Center. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00814333, a NA study, was terminated before completion, sponsored by University of Kansas Medical Center.

TERMINATED
Registry status
NA
Development phase
1 participants
Enrollment target

Study Summary

Epistaxis is a common problem among people of all ages and backgrounds. However, occasionally epistaxis can be severe enough to require emergency room admission. Among the treatment options for epistaxis, nasal packing is the most common approach. This approach requires a return visit to the clinic for removal of the packing. Additionally, there is a great deal of pain during the insertion and removal of this packing. This study aims to justify the further investigation of thrombin as a potential treatment approach for these patients. Thrombin could provide a treatment approach that reduces pain and eliminates the need for a return visit to the clinic.

Interventions

  • DRUG Thrombin-JMI
  • DRUG Merocel pack

Trial Details

FieldValue
Enrollment Target 1 participants
Start Date 2008-12
Est. Completion 2011-08
Phase NA
University of Kansas Medical Center

408 total trials

Why NCT00814333 stopped before completion

NCT00814333 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 2 interventions - of which Thrombin-JMI is the first listed.

NCT00814333 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00814333 about?

NCT00814333 is a clinical study titled "Trial Comparing Outcomes With Merocel Packing or Thrombin-JMI for Anterior Epistaxis". Epistaxis is a common problem among people of all ages and backgrounds. However, occasionally epistaxis can be severe enough to require emergency room admission. Among the treatment options for epistaxis, nasal packing is the most common approach. This approach requires a return visit to the clinic ...

What is the current status of trial NCT00814333?

This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2008-12. Estimated completion is 2011-08.

What interventions are being tested in trial NCT00814333?

The interventions under investigation include: Thrombin-JMI (DRUG), Merocel pack (DRUG).

Who is sponsoring clinical trial NCT00814333?

This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00814333's enrollment target sits among peer trials

1 2001st of 2000 the lowest of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00814333, the US trial registry maintained by the National Library of Medicine. NCT00814333 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.